Objectives

After participating in this educational activity, attendees should be able to:
1| describe the approach to the management of HIV-infected individuals with multiclass resistance.
2| Review data on a newly approved antiretroviral agent.
 

Faculty

Daniel J. Skiest, MD

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the other members of the planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

Session date: 
Thursday, November 12, 2020 - 12:00pm to 1:00pm
Location: 
Webinar
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.